Amprenavir: Difference between revisions
Jump to navigation
Jump to search
imported>David E. Volk (New page: {{subpages}} right|thumb|200px|{{#ifexist:Template:Amprenavir structure.jpg/credit|{{Amprenavir structure.jpg/credit}}<br/>|}}Amprenavir. '''Amprenavir...) |
mNo edit summary |
||
| (7 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
[[Image:Amprenavir structure.jpg| | |||
{{Chem infobox | |||
|align=right | |||
|image=[[Image:Amprenavir structure.jpg|center|thumb|200px]] | |||
|width=200px | |||
|molname=amprenavir | |||
|synonyms= AMP, AMV, APV, VX-478 | |||
|molformula= C<sub>25</sub>H<sub>35</sub>N<sub>3</sub>O<sub>6</sub>S | |||
|molmass= 505.6269 | |||
|uses=HIV | |||
|properties=protease inhibitor | |||
|hazards=see drug interactions | |||
|iupac= see chemistry section | |||
|casnumber= 161814-49-9 | |||
}} | |||
'''Amprenavir''', also called AMP, AMV, APV and VX-478, is a protease inhibitor used to treat HIV infection. Protease inhibitors block HIV-1 protease, an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. | |||
'''Amprenavir''', also called AMP, AMV, APV and VX-478, is a [[protease inhibitor]] used to treat HIV infection. Protease inhibitors block HIV-1 protease, an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. Its IUPAC chemical name is [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3- | |||
hydroxy-1-phenylbutan-2-yl]carbamate. | |||
== Brand Names == | == Brand Names == | ||
| Line 10: | Line 26: | ||
== External Links == | == External Links == | ||
{{CZMed}}[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 06:00, 10 July 2024
|
| |||||||
| amprenavir | |||||||
| |||||||
| Uses: | HIV | ||||||
| Properties: | protease inhibitor | ||||||
| Hazards: | see drug interactions | ||||||
| |||||||
Amprenavir, also called AMP, AMV, APV and VX-478, is a protease inhibitor used to treat HIV infection. Protease inhibitors block HIV-1 protease, an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs. Its IUPAC chemical name is [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-
hydroxy-1-phenylbutan-2-yl]carbamate.
Brand Names
- Agenerase®
- Prozei®
- Vertex®
External Links
The most up-to-date information about Amprenavir and other drugs can be found at the following sites.
- Amprenavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Amprenavir - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Amprenavir - Detailed information from DrugBank.